Kriti Nutrients Ltd. Conducts 30th AGM; Approves Interim Dividend & Director Re-appointments
Kriti Nutrients Limited held its 30th AGM on August 12, 2026. The company approved its FY26 financial statements and an interim dividend of ₹3.00 per share. Mr. Saurabh Singh Mehta was re-appointed as Director and his remuneration revised. M/s M Mehta & Company were re-appointed as Statutory Auditors for 5 years.
The event is a routine annual general meeting with standard corporate actions like dividend approval and director re-appointments. While important for governance, it does not signal a significant shift in business strategy or immediate financial performance impact.
The announcement details the successful conclusion of the Annual General Meeting, with key approvals for financial statements, dividends, and director re-appointments, indicating smooth governance and operational continuity.
Kriti Nutrients Limited held its 30th Annual General Meeting (AGM) on Wednesday, August 12, 2026, conducted entirely through Video Conferencing (VC) or Other Audio Video Means (OAVM). The meeting, which commenced at 4:30 P.M. IST and concluded at 5:02 P.M. IST, was deemed to have taken place at the company's corporate office in Indore.
The AGM proceedings included the adoption of the Audited Standalone and Consolidated Financial Statements for the financial year ended March 31, 2026. Shareholders also approved the interim dividend of ₹3.00 (300%) per equity share, amounting to ₹1503.11 Lakhs, declared and paid on November 8, 2025, confirming it as the full and final dividend for FY 2025-26.
Key decisions also involved the re-appointment of Mr. Saurabh Singh Mehta as a Director retiring by rotation, and the re-appointment of M/s M Mehta & Company as Statutory Auditors for a second consecutive term of 5 years, until the 35th AGM in 2031. The remuneration of the Cost Auditor for FY 2026-27 was ratified, with M/s Dhananjay V. Joshi & Associates appointed at ₹35,000 plus applicable taxes and expenses.
Furthermore, the meeting saw the approval of revised remuneration for Mr. Saurabh Singh Mehta as Whole-time Director and Joint Managing Director, effective from April 1, 2026, to July 31, 2027, and his re-appointment for a further term of 3 years from August 1, 2027, to July 31, 2030. The re-appointment and remuneration of Mr. Shiv Singh Mehta as Chairman and Managing Director for a term of 3 years from January 12, 2027, to January 11, 2030, were also approved, with provisions for remuneration exceeding 5% of net profits in certain cases.
The results of the e-voting, along with the scrutinizer's report, will be communicated within two working days and will be made available on the company's and stock exchanges' websites. The recorded transcript of the AGM will also be placed on the company's website.
What to do with a filing like this
Kriti Nutrients Limited filed this with the NSE as a statutory disclosure, categorised under agm. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Kriti Nutrients Limited. Read the original for the full detail.